
Oncology
Latest News
Advertisement
Latest Videos

CME Content
Advertisement
More News
























As we near the first anniversary of the Oncology Care Model, CMS' bundled payment program for oncology, explore why practices are participating and the challenges they have faced over the past 9 months.

Tumor response rate and progression-free survival were the benchmarks that helped pembrolizumab (Keytruda) gain accelerated approval as first-line treatment for metastatic nonsquamous non-small cell lung cancer (NSCLC), in combination with chemotherapy.
Advertisement
Advertisement
Trending on AJMC
1
Cefdinir Nearly Doubles Outpatient Uncomplicated UTI Treatment Failure Compared With Cephalexin
2
Stronger Carer-Child Bonds Don’t Predict Later Mental Health
3
Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen
4
FDA to Remove Black Box Warnings From HRT, Debate Ensues
5

























































